Watchman Group, Inc. Abb Vie Inc. Transaction History

Watchman Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $214,216 - $235,826	-2,094 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $168,546 - $227,554	2,094 New	2,094 $224,000
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $179,895 - $211,138	-2,094 Closed	0 $0
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $153,636 - $205,588	2,094 New	2,094 $206,000
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $160,863 - $243,888	-2,494 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $179,892 - $225,083	2,494 New	2,494 $221,000

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Watchman Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Watchman Group, Inc. with notifications on news.